tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Haemonetics price target lowered to $81 from $99 at Baird
PremiumThe FlyHaemonetics price target lowered to $81 from $99 at Baird
1M ago
Haemonetics price target lowered to $80 from $90 at Mizuho
Premium
The Fly
Haemonetics price target lowered to $80 from $90 at Mizuho
1M ago
Haemonetics price target raised to $94 from $93 at Barrington
Premium
The Fly
Haemonetics price target raised to $94 from $93 at Barrington
1M ago
Balancing Plasma Strength Against Vascular Closure Uncertainty: Maintaining a Neutral (Hold) View on Haemonetics
PremiumRatingsBalancing Plasma Strength Against Vascular Closure Uncertainty: Maintaining a Neutral (Hold) View on Haemonetics
2M ago
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
Premium
The Fly
Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition
2M ago
Haemonetics price target raised to $93 from $90 at Barrington
Premium
The Fly
Haemonetics price target raised to $93 from $90 at Barrington
2M ago
Haemonetics downgraded to Hold from Buy at Needham
PremiumThe FlyHaemonetics downgraded to Hold from Buy at Needham
3M ago
Haemonetics price target raised to $74 from $62 at JPMorgan
Premium
The Fly
Haemonetics price target raised to $74 from $62 at JPMorgan
3M ago
Haemonetics downgraded to Neutral from Buy at Citi
Premium
The Fly
Haemonetics downgraded to Neutral from Buy at Citi
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100